How pharma could feel the pain of a recession
PharmaVoice
MARCH 21, 2025
Pharma has long been considered “recession proof,” but an economic downturn could still hurt the industry in numerous ways.
Fri.Mar 21, 2025
232 
FarmboxRx Introduces Platform for Addressing SDOH Needs
MedCity News
MARCH 21, 2025
FarmboxRx’s new platform provides tailored support to help members engage with their health benefits. The post FarmboxRx Introduces Platform for Addressing SDOH Needs appeared first on MedCity News.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Alnylam joins three-way contest in ATTR cardiomyopathy
pharmaphorum
MARCH 21, 2025
Alnylam has claimed FDA approval for Amvuttra in ATTR cardiomyopathy, allowing it to compete with rival therapies from Pfizer and BridgeBio.
J&J boosts US operations with $55bn investment
Pharmaceutical Technology
MARCH 21, 2025
J&J is the latest pharma company to announce a major US investment, committing to a $55bn influx in the next four years.
State of AI in Sales & Marketing 2025
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Fabhalta is first FDA-approved therapy for rare disease C3G
pharmaphorum
MARCH 21, 2025
Novartis' oral complement inhibitor Fabhalta has become the first approved treatment for rare kidney disease C3G as it chases a $3bn sales target
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
PAP 2025: Boosting Patient Empowerment
Pharmaceutical Commerce
MARCH 21, 2025
The presentation suggests ways to educate patients on the options available to them, with the hope of ultimately improving health outcomes.
FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease
Pharmaceutical Technology
MARCH 21, 2025
J&J has received US FDA approval for Tremfya (guselkumab), to treat moderately to severely active Crohn's disease (CD) in adults.
APhA 2025: Pharmacists Can Prescribe Contraceptives in 30 States and the District of Columbia
Pharmacy Times
MARCH 21, 2025
Contraceptive options have expanded since 1960, with pharmacists today playing a growing role as prescribers of contraception and studies showing the benefit of pharmacist-driven contraception clinics.
Global funding cuts reversing decades of tuberculosis progress, WHO says
Pharmaceutical Technology
MARCH 21, 2025
Ahead of World Tuberculosis Day on 24 March, the WHO has said that global funding cuts are curtailing efforts to fight the disease.
The Intersection of AI and Sales: Personalization Without Compromise
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
CDC Launches Study on Vaccine-Autism Link Amid Ongoing Measles Outbreak
Pharmacy Times
MARCH 21, 2025
The study aims to address lingering public concerns, but its findings and communication have the potential to impact vaccine confidence and public health efforts.
Mastering compliance and copyright in healthcare and MedComms
Pharmaceutical Technology
MARCH 21, 2025
Understanding reuse rights and copyright compliance is critical, particularly in todays ever-evolving technological landscape.
AZ builds in China, as J&J ramps up its US investments
pharmaphorum
MARCH 21, 2025
AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.
European agencies catch up with speedier regulatory pathways for CGTs in the US
Pharmaceutical Technology
MARCH 21, 2025
Shorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts.
The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
EMA panel endorses AI for MASH clinical trials
pharmaphorum
MARCH 21, 2025
PathAI's artificial intelligence tool for diagnosing MASH has become the first to be recommended under the EMA's Qualification Opinion framework.
Heart Failure With Improved Ejection Fraction Is a Rising Focus in Cardiovascular Care
Pharmacy Times
MARCH 21, 2025
This subset of heart failure requires unique therapeutic considerations.
J&J adds to IL-23 options in Crohn's after FDA approval
pharmaphorum
MARCH 21, 2025
J&J's Tremfya gets a much-anticipated FDA approval for Crohn's disease, which the company thinks will be key to a renewed phase of sales growth.
BCMA-Targeting CAR T-Cell Therapy Is Feasible in Patients With Multiple Myeloma and CNS Involvement
Pharmacy Times
MARCH 21, 2025
Patients with central nervous system (CNS) involvement achieved favorable outcomes with chimeric antigen receptor (CAR) T-cell therapy.
AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
PAP 2025: The Ongoing Challenge for Nonprofit Patient Assistance Programs
Pharmaceutical Commerce
MARCH 21, 2025
Jonathan James, CEO, Hope Charities, discusses the challenge of nonprofits securing sustainable funding while ensuring patients are aware of available assistance.
Johnson & Johnson to Invest Over $55 Billion in US Manufacturing Facilities
PharmExec
MARCH 21, 2025
The investment, which is a 25% increase from previous years, will support three new advanced manufacturing facilities, expansions at existing sites, and R&D efforts.
ITT Brands’ Industry 4.0 Solutions for Flow Control to Be Shown at INTERPHEX
PharmaTech
MARCH 21, 2025
Upgraded and dynamic valve platforms as well as advanced sensing will be some of the components of ITTs exhibit.
FDA Approves Johnson & Johnson’s Tremfya for Crohn Disease
PharmExec
MARCH 21, 2025
Tremfya is the first and only IL-23 inhibitor with both subcutaneous and intravenous induction options for adults with moderately to severely active Crohn disease in the United States.
5 Ways You Can Win Faster with Gen AI in Sales
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
How to manage regulatory complexities with clinical trial data
Pharmaceutical Technology
MARCH 21, 2025
Clinical trials must use effective electronic data capture platforms that prioritise data integrity and comply with regulations.
Pharma Pulse 3/21/25: Pregnant Women Underrepresented in Clinical Trials, The Future of Value-Based Care & more
PharmExec
MARCH 21, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharma Pulse 3/21/25: The Biggest Bottlenecks for Patients, Age and Comorbidities Drive RSV Hospitalization Rates & more
Pharmaceutical Commerce
MARCH 21, 2025
The latest news for pharma industry insiders.
The Cigna Group Completes Sale of Medicare Businesses
PharmExec
MARCH 21, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Futureproofing Pharma Supply Chains
Pharmaceutical Commerce
MARCH 21, 2025
In the fourth part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDOs national life sciences co-leader, addresses how AI can help support pharma leaders with managing their supply chains and addressing potential material shortages.
Strategies to Address Rising Medication Costs & Improve Patient Access
PharmExec
MARCH 21, 2025
Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, identifies innovative strategies and solutions for addressing the rising cost of medications and improving patient access.
Nipocalimab Is Granted Fast Track Designation for Treatment of Patients With Sjögren’s Disease
Pharmacy Times
MARCH 21, 2025
Sjgren's disease is one of the most common chronic autoimmune diseases that affects 4 million individuals around the world.
Let's personalize your content